Enalapril

Pregnancy & gynaecology-specific. Every dose row is source-referenced; verify against institutional protocols.

EnalaprilAntihypertensive / ACE inhibitor

Regimens checked: 2026-10-17. Each indication has its own preparation, limits and safety checks.

Enalapril: indication-specific regimens
Indication	Dose	Route	Frequency	Duration / preparation	Maximum	Monitoring / cautions
After birth only; NICE recommends enalapril with maternal renal-function and potassium monitoring Milpharm / emcchecked	Start 5 mg once daily; use a lower supervised initial dose if volume depleted or renally impaired; titrate to BP response	Oral	Once daily initially	Review BP and dose after birth; reduce/stop as hypertension resolves or continue for persistent hypertension after medical review · 5 mg tablet swallowed with water, with or without food. Correct volume depletion; check creatinine and potassium before starting NICE NG133 supplies the postpartum choice. Breastfeeding requires extra caution with premature/very young infants; use a suitable alternative when clinically indicated. Renal / hepatic: Renal impairment requires a lower initial dose and adjustment from the product renal table, not the unadjusted 5 mg starter.	40 mg/day in the product label; usual maintenance 20 mg/day, not an automatic postpartum target	Monitor BP, symptoms, creatinine/eGFR and potassium before and after initiation/dose changes; infant feeding, alertness and urine output if breastfeeding Contraindications / cautions Pregnancy, prior ACE-inhibitor angioedema, significant hyperkalaemia; avoid starting in unresolved AKI or severe volume depletion

Pregnancy safety

Use postpartum; do not initiate during pregnancy

Lactation

Postpartum option with infant and maternal monitoring